Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats

Virology

Volumn 256, Issue 2, 1999, Pages 203-212

  Fujii, Shigemoto ^a   Akaike, Takaaki ^a   Maeda, Hiroshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE; N(G) METHYL DEXTRO ARGININE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN STEM; CEREBELLUM; ELECTRON SPIN RESONANCE; HERPES SIMPLEX VIRUS 1; IMMUNOHISTOCHEMISTRY; NONHUMAN; NORTHERN BLOTTING; OLFACTORY BULB; PARALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEIZURE; VIRUS ENCEPHALITIS; VIRUS LOAD; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0033541374     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9610     Document Type: Article

References (44)

1. Adachi H., Iida S., Oguchi S., Ohshima H., Suzuki H., Nagasaki K., Kawasaki H., Sugimura T., Esumi H. Molecular cloning of a cDNA encoding an inducible calmodulin-dependent nitric-oxide synthase from rat liver and its expression in COS 1 cells. Eur. J. Biochem. 217:1993;37-43.
2. Adler H., Beland J. L., Del-Pan N. C., Kobzik L., Brewer J. P., Martin T. R., Rimm I. J. Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J. Exp. Med. 185:1997;1533-1540.
3. Akaike T., Weihe E., Schaefer M., Fu Z. F., Zheng Y. M., Vogel W., Schmidt H., Koprowski H., Dietzschold B. Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain. J. Neurovirol. 1:1995;118-125.
4. Akaike T., Noguchi Y., Ijiri S., Setoguchi K., Suga M., Zheng Y. M., Dietzschold B., Maeda H. Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA. 93:1996;2448-2453.
5. Akaike T., Suga M., Maeda H. Free radicals in viral pathogenesis: Molecular mechanisms involving superoxide and NO. Proc. Soc. Exp. Biol. Med. 217:1998;64-73.
6. Aoki H., Akaike T., Abe K., Kuroda M., Arai S., Okamura R., Negi A., Maeda H. Antiviral effect of oryzacystatin, a proteinase inhibitor in rice, against herpes simplex virus 1 in vitro and in vivo. Antimicrob. Agents Chemother. 39:1995;846-849.
7. Beckman, J. B., and Koppenol, W. H.1996. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am. J. Physiol.271 [Cell Physiol.40], C1424-C1437.
8. Beckman, J. B., and Koppenol, W. H.1996. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am. J. Physiol.271 [Cell Physiol.40], C1424-C1437.
9. Beers D. R., Henkel J. S., Schaefer D. C., Rose J. W., Stroop W. G. Neuropathology of herpes simplex virus encephalitis in a rat seizure model. J. Neuropathol. Exp. Neurol. 52:1993;241-252.
10. Bi Z., Barna M., Komatsu T., Reiss C. S. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J. Virol. 69:1995;6466-6472.
11. Bukrinsky M. I., Nottet H. S. L. M., Schmidtmayerova H., Dubrovsky L., Flanagan C. R., Mullins M. E., Lipton S. A., Gendelman H. E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J. Exp. Med. 181:1995;735-745.
12. Choi D. W. Nitric oxide: Foe or friend to the injured brain? Proc. Natl. Acad. Sci. USA. 90:1993;9741-9743.
13. Croen K. D. Evidence for an antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91:1993;2446-2452.
14. Doi K., Akaike T., Fujii S., Ikebe N., Beppu T., Ogawa M., Maeda H. Induction of heme oxygenase and nitric oxide synthase in an experimental tumor in rats and its implication for tumor growth. Moncada S., Toda N., Maeda H., Higgs E. A. The Biology of Nitric Oxide Part 6. 1998;187 Portland Press, London.
15. Doi T., Ando M., Akaike T., Suga M., Sato K., Maeda H. Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis. Infect. Immun. 61:1993;1980-1989.
16. Estévez A. G., Radi R., Barbeito L., Shin J. T., Thompson J. A., Beckman J. S. Peroxynitrite-induced cytotoxicity in PC12 cells: Evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J. Neurochem. 65:1995;1543-1550.
17. Furchgott R. F., Vanhoutte P. M. Endothelium-derived relaxing and contracting factors. FASEB J. 3:1989;2007-2018.
18. Granger D. L., Hibbs J. B. Jr., Perfect J. R., Durack D. T. Specific amino acid (l-arginine) requirement for microbiostatic activity of murine macrophages. J. Clin. Invest. 81:1988;1129-1136.
19. James S. L. Role of nitric oxide in parasitic infections. Microbiol. Rev. 59:1995;533-547.
20. Karupiah G., Xie Q., Buller R. M. L., Nathan C., Duarte C., MacMicking J. D. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science. 261:1993;1445-1448.
21. Kim Y.-M., Bergonia H. A., Müller C., Pitt B. R., Watkins W. D., Lancaster J. R. Jr. Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J. Biol. Chem. 270:1995;5710-5713.
22. Kimura H., Futamura M., Kito H., Ando T., Goto M., Kuzushima K., Shibata M., Morishima T. Detection of viral DNA in neonatal herpes simplex virus infections: Frequent and prolonged presence in serum and cerebrospinal fluid. J. Infect. Dis. 164:1991;289-293.
23. Koprowski H., Zheng Y. M., Heber-Katz E., Fraser N., Rorke L., Fu Z. F., Hanlon C., Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. USA. 90:1993;3024-3027.
24. Kreil T. R., Eibl M. M. Nitric oxide and viral infection: No antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo. Virology. 219:1996;304-306.
25. Landino L. M., Crews B. C., Timmons M. D., Morrow J. D., Marnett L. J. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc. Natl. Acad. Sci. USA. 93:1996;15069-15074.
26. Lane T. E., Paoletti A. D., Buchmeier M. J. Dissociation between the in vitro and in vivo effects of nitric oxide on a neurotropic coronavirus. J. Virol. 71:1997;2202-2210.
27. Lipton S. A., Choi Y.-B., Pan Z.-H., Lei S. Z., Chén H.-S. V., Sucher N. J., Loscalzo J., Singel D. J., Stamler J. S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
28. MacLean A., Wei X.-Q., Huang F.-P., Al-Alem U. A. H., Chan W. L., Liew F. Y. Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th 1 cell responses. J. Gen. Virol. 79:1998;825-830.
29. Maines M. D. The heme oxygenase system: A regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37:1997;517-554.
30. Mannick J. B., Asano K., Izumi K., Kieff E., Stamler J. S. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 79:1994;1137-1146.
31. Melino G., Bernassola F., Knight R. A., Corasaniti M. T., Finazzi-Agró G. N. A. S-Nitrosylation regulates apoptosis. Nature. 388:1997;432-433.
32. ω-nitro-l-arginine methyl ester treatment improves survival rate and decreases myocardial injury in a murine model of viral myocarditis induced by coxsackievirus B3. Circ. Res. 81:1997;504-511.
33. Moncada S., Higgs A. The l-arginine-nitric oxide pathway. N. Engl. J. Med. 329:1993;2002-2012.
34. Nathan C. Inducible nitric oxide synthase: What difference does it make? J. Clin. Invest. 100:1997;2417-2423.
35. Nathan C. F., Hibbs J. B. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:1991;65-70.
36. Okamoto T., Akaike T., Nagano T., Miyajima S., Suga S., Ando M., Ichimori K., Maeda H. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: A novel mechanism of procollagenase activation involving nitric oxide. Arch. Biochem. Biophys. 342:1997;261-274.
37. Rolph M. S., Ramshaw I. A., Rockett K. A., Ruby J., Cowden W. B. Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance. Virology. 217:1996;470-477.
38. Rubbo H., Darley-Usmar V., Freeman B. A. Nitric oxide regulation of tissue free radical injury. Chem. Res. Toxicol. 9:1996;809-820.
39. Setoguchi K., Takeya M., Akaike T., Suga M., Hattori R., Maeda H., Ando M., Takahashi K. Expression of inducible nitric oxide synthase and its involvement in pulmonary granulomatous inflammation in rats. Am. J. Pathol. 149:1996;2005-2022.
40. Takeda A., Onodera H., Sugimoto A., Itoyama Y., Kogure K., Shibahara S. Increased expression of heme oxygenase mRNA in rat brain following transient forebrain ischemia. Brain Res. 666:1994;120-124.
41. Umezawa K., Akaike T., Fujii S., Suga M., Setoguchi K., Ozawa A., Maeda H. Induction of nitric oxide synthesis and xanthine oxidase and their role in the antimicrobial mechanism against Salmonella typhimurium in mice. Infect. Immun. 65:1997;2932-2940.
42. Zaragoza C., Ocampo C., Saura M., Leppo M., Wei X.-Q., Quick R., Moncada S., Liew F. Y., Lowenstein C. J. The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. Proc. Natl. Acad. Sci. USA. 95:1998;2469-2474.
43. Zaragoza C., Ocampo C. J., Saura M., McMillian A., Lowenstein C. J. Nitric oxide inhibition of coxsackievirus replication in vitro. J. Clin. Invest. 100:1997;1760-1767.
44. Zheng Y. M., Schöfer M. K. H., Weihe E., Sheng H., Corisdeo S., Fu Z. F., Koprowski H., Dietzschold B. Severity of neurological signs and degree of inflammatory lesions in the brains of the rats with Borna disease correlate with the induction of nitric oxide synthase. J. Virol. 67:1993;5786-5791.